Whitehawk Therapeutics Inc Stock Analysis & AI Score
Whitehawk Therapeutics Inc (WHWK) has an ST Score of 51.4 (C+), driven by its Financial Strength (A+) and held back by its Growth (D-). WHWK last traded at $3.86.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Whitehawk Therapeutics Inc (WHWK) has an ST Score of 51.4 (C+), driven by its Financial Strength (A+) and held back by its Growth (D-). WHWK last traded at $3.86.
- Strongest
- Financial StrengthA+
- Weakest
- GrowthD-
All factor grades
- Financial StrengthA+
- ForecastA
- ValuationB-
- MomentumB-
- ProfitabilityC+
- GrowthD-
- Piotroski1/9
Contact
WHWK stock: frequently asked questions
What is WHWK's ST Score?
Whitehawk Therapeutics Inc (WHWK) has an ST Score of 51.4 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is WHWK a buy, hold, or sell?
Our ST Score grades it C+ (51.4/100). The ST Score is a data-driven signal, not a recommendation.
What are WHWK's factor grades?
Valuation B-, Profitability C+, Financial Strength A+, Momentum B-, Growth D-, Forecast A.
What is WHWK's valuation grade?
Whitehawk Therapeutics Inc (WHWK) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is WHWK's growth grade?
Whitehawk Therapeutics Inc (WHWK) earns a growth grade of D-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is WHWK's profitability grade?
Whitehawk Therapeutics Inc (WHWK) earns a profitability grade of C+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is WHWK's financial strength grade?
Whitehawk Therapeutics Inc (WHWK) earns a financial strength grade of A+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for WHWK?
The average analyst price target for Whitehawk Therapeutics Inc (WHWK) is $8.00, which is +107.3% versus the recent price of $3.86.
What is WHWK's Piotroski score?
Whitehawk Therapeutics Inc (WHWK) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.